Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Atherosclerosis
|
May 1, 1989
The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors
D W Swinkels, P N Demacker, J C Hendriks, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 20, 1995
[Preoperative internist consultation. II. Management in hypertension and cardiac disease]
A A Kroon, H Wollersheim, P P Koopmans, et al.
The Netherlands Journal of Medicine
|
April 1, 1995
Long-term experience (6 years) with simvastatin in patients with heterozygous familial hypercholesterolaemia
R E Knops, A A Kroon, M J Mol, et al.
British Medical Journal (Clinical Research Ed.)
|
April 24, 1982
Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations
P N Demacker, R W Schade, A F Stalenhoef, et al.
European Journal of Clinical Investigation
|
April 1, 1991
Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids
P N Demacker, I G Reijnen, M B Katan, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
June 1, 1989
Apo E polymorphism and the removal of remnants of triglyceride-rich lipoproteins in normolipidemic subjects during a carbohydrate-rich diet
B J Brenninkmeijer, P M Stuyt, P N Demacker, et al.
Biochemical and Biophysical Research Communications
|
July 13, 2000
Familial chylomicronemia caused by a novel type of mutation in the APOE-CI-CIV-CII gene cluster encompassing both the APOCII gene and the first APOCIV gene mutation: APOCII-CIV(Nijmegen)
J de Graaf, M J Hoffer, P M Stuyt, et al.
Lancet (London, England)
|
March 5, 1983
Lipoprotein associated isoproteins in a patient with cholesterol emboli resulting in renal failure
P N Demacker, P M Stuyt, A van't Laar, et al.
The American Journal of Medicine
|
January 1, 1990
Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia)
P M Stuyt, M J Mol, A F Stalenhoef, et al.
Journal of Lipid Research
|
September 1, 1988
Identification of apolipoprotein E polymorphism by using synthetic oligonucleotides
H J Smeets, J Poddighe, P M Stuyt, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Atherosclerosis
|
May 1, 1989
The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors
D W Swinkels, P N Demacker, J C Hendriks, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 20, 1995
[Preoperative internist consultation. II. Management in hypertension and cardiac disease]
A A Kroon, H Wollersheim, P P Koopmans, et al.
The Netherlands Journal of Medicine
|
April 1, 1995
Long-term experience (6 years) with simvastatin in patients with heterozygous familial hypercholesterolaemia
R E Knops, A A Kroon, M J Mol, et al.
British Medical Journal (Clinical Research Ed.)
|
April 24, 1982
Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations
P N Demacker, R W Schade, A F Stalenhoef, et al.
European Journal of Clinical Investigation
|
April 1, 1991
Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids
P N Demacker, I G Reijnen, M B Katan, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
June 1, 1989
Apo E polymorphism and the removal of remnants of triglyceride-rich lipoproteins in normolipidemic subjects during a carbohydrate-rich diet
B J Brenninkmeijer, P M Stuyt, P N Demacker, et al.
Biochemical and Biophysical Research Communications
|
July 13, 2000
Familial chylomicronemia caused by a novel type of mutation in the APOE-CI-CIV-CII gene cluster encompassing both the APOCII gene and the first APOCIV gene mutation: APOCII-CIV(Nijmegen)
J de Graaf, M J Hoffer, P M Stuyt, et al.
Lancet (London, England)
|
March 5, 1983
Lipoprotein associated isoproteins in a patient with cholesterol emboli resulting in renal failure
P N Demacker, P M Stuyt, A van't Laar, et al.
The American Journal of Medicine
|
January 1, 1990
Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia)
P M Stuyt, M J Mol, A F Stalenhoef, et al.
Journal of Lipid Research
|
September 1, 1988
Identification of apolipoprotein E polymorphism by using synthetic oligonucleotides
H J Smeets, J Poddighe, P M Stuyt, et al.
Page
of 6